Adverum Biotechnologies Inc

Adverum Biotechnologies — Proxy Contest (April 2021)

10 slides from Adverum Biotechnologies's proxy contest presentation, Apr 26, 2021

  1. Slide 1: Adverum's Myths: Correcting the Record

    Slide 1: Adverum's Myths: Correcting the Record

    Adverum’s Myths: Correcting the Record April 26, 2021 www.SaveAdverum.com

  2. Slide 2: Disclaimer

    Slide 2: Disclaimer

    Disclaimer THIS PRESENTATION IS FOR DISCUSSION AND GENERAL INFORMATIONAL PURPOSES ONLY. IT DOES NOT HAVE REGARD TO THE SPECIFIC INVESTMENT OBJECTIVE, FINANCIAL SITUATION, SUITABILITY, OR THE PARTICULAR NEED OF ANY SPECIFIC PERSON WHO MAY RECEIVE THIS PRESENTATION, AND SHOULD NOT BE TAKEN AS ADVICE O

  3. Slide 3: This Contest Boils Down To Assembling the Best Possible Board at Adverum

    Slide 3: This Contest Boils Down To Assembling the Best Possible Board at Adverum

    This Contest Boils Down To Assembling the Best Possible Board at Adverum ❑ Sonic’s sole aim in this contest is to ensure that Adverum has the best Board possible to ensure the development and eventual approval of the Company’s potentially life-changing treatment for wet age-related macular degenerat

  4. Slide 4: Adverum Expects Stockholders to Adopt a "Wait and See" Posture

    Slide 4: Adverum Expects Stockholders to Adopt a "Wait and See" Posture

    Adverum Expects Stockholders to Adopt a “Wait and See” Posture Adverum does not seem to trust its stockholders with This is not the conduct of a What is Adverum afraid of? selecting members of the Board that is confident of: Board This is evidenced by the games The talent and independence That indep

  5. Slide 5: Adverum's Myths vs. The Reality

    Slide 5: Adverum's Myths vs. The Reality

    Adverum’s Myths vs. The Reality

  6. Slide 6: Myth vs. Reality (1 of 3)

    Slide 6: Myth vs. Reality (1 of 3)

    Myth vs. Reality (1 of 3) Adverum’s Myth* The Reality ❑ So the Board admits that it will be expanding the Board after the 2021 Annual “The Adverum Board made it a priority and has Meeting – thereby depriving stockholders of a vote on this “to be determined” already begun a process to recruit and nam

  7. Slide 7: Myth vs. Reality (2 of 3)

    Slide 7: Myth vs. Reality (2 of 3)

    Myth vs. Reality (2 of 3) Adverum’s Myth The Reality ❑ This is absolutely false. First, stockholders should have the chance to “Not only is our process better than forcing people vote for the best director candidates onto our Board through a contest, but what Sonic is ❑ Second, our slate has broad d

  8. Slide 8: Myth vs. Reality (3 of 3)

    Slide 8: Myth vs. Reality (3 of 3)

    Myth vs. Reality (3 of 3) Adverum’s Myth The Reality Sonic is “Focused on capricious and unfocused ❑ We are not asking shareholders to elect Sonic to the Board. All of our ideas that divert resources away from ADVM-022 candidates are fully independent and distract Adverum from development of its ❑ C

  9. Slide 9: Conclusion

    Slide 9: Conclusion

    Conclusion Sonic’s nominees would bring fresh perspective, independence and extraordinary talent to the Board Such improvement is also important from a governance perspective at a Company that still has a classified Board Also of note is that Company nominee Thomas Woiwode sits on the Board of sever

  10. Slide 10: Contacts

    Slide 10: Contacts

    Contacts Investors John Ferguson Saratoga Proxy Consulting LLC (212) 257-1311 Info@saratogaproxy.com Media Joe Germani / Sarah Braunstein Sloane & Company jgermani@sloanepr.com / sbraunstein@sloanepr.com

Source: SEC EDGAR · DFAN14A filed Apr 26, 2021

More decks from Adverum Biotechnologies Inc